Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G
Internal Medicine and Cardiovascular Diseases Unit, Department of Medicina Sperimentale e Clinica "G. Salvatore," University of Catanzaro Magna Graecia, Catanzaro, Italy.
Circulation. 2001 Jul 10;104(2):191-6. doi: 10.1161/01.cir.104.2.191.
Forearm endothelial dysfunction, characterized by an impaired vasodilating response to acetylcholine (ACh), may be associated with several cardiovascular risk factors, including essential hypertension. Although the prognostic value of coronary endothelial dysfunction has been demonstrated, that of forearm endothelial dysfunction is still unknown. Methods and Results-- Endothelium-dependent and -independent vasodilation was investigated in 225 never-treated hypertensive patients (age, 35 to 54 years) by intra-arterial infusion of increasing doses of ACh and sodium nitroprusside. Patients were divided into tertiles on the basis of their increase in ACh-stimulated forearm blood flow (FBF) from basal: group 1, from 30% to 184%; group 2, from 185% to 333%; and group 3, from 339% to 760% increase from basal. During a mean follow-up of 31.5 of months (range, 4 to 84 months), there were 29 major adverse events at the cardiac (n=19), cerebrovascular (n=9), or peripheral vascular (n=1) level. Events included myocardial infarction, angina, coronary revascularization procedures, stroke, transient cerebral ischemic attack, and aortoiliac occlusive disease. Event rate per 100 patient-years was 8.17, 4.34, and 2.02 in the first, second, and third tertiles of peak percent increase in FBF during ACh infusion. The excess risk associated with an FBF increase in the first tertile was significant (relative risk, 2.084; 95% CI, 1.25 to 3.48; P=0.0049) after controlling for individual risk markers, including 24-hour ambulatory blood pressure.
Our data suggest that forearm endothelial dysfunction is a marker of future cardiovascular events in patients with essential hypertension.
以对乙酰胆碱(ACh)血管舒张反应受损为特征的前臂内皮功能障碍,可能与包括原发性高血压在内的多种心血管危险因素相关。尽管冠状动脉内皮功能障碍的预后价值已得到证实,但前臂内皮功能障碍的预后价值仍不清楚。方法与结果——通过动脉内输注递增剂量的ACh和硝普钠,对225例未经治疗的高血压患者(年龄35至54岁)进行内皮依赖性和非依赖性血管舒张研究。根据ACh刺激后前臂血流量(FBF)相对于基础值的增加幅度,将患者分为三分位数:第1组,增加30%至184%;第2组,增加185%至333%;第3组,增加339%至760%。在平均31.5个月(范围4至84个月)的随访期间,心脏、脑血管或外周血管水平发生了29起主要不良事件。事件包括心肌梗死、心绞痛、冠状动脉血运重建术、中风、短暂性脑缺血发作和主髂动脉闭塞性疾病。在ACh输注期间,FBF峰值增加百分比的第一、第二和第三三分位数中,每100患者年的事件发生率分别为8.17、4.34和2.02。在控制了包括24小时动态血压在内的个体风险标志物后,第一三分位数中FBF增加相关的额外风险显著(相对风险,2.084;95%可信区间,1.25至3.48;P=0.0049)。
我们的数据表明,前臂内皮功能障碍是原发性高血压患者未来心血管事件的一个标志物。